Granulocyte—Macrophage Colony—Stimulating Factor in Newly Diagnosed Adult Patients with Acute Lymphoblastic Leukemia Treated with Conventional Chemotherapy

References

• Levine, A. S., Chimpff, S. C., Graw, R. G., Young, R. C. (1974). Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin. Hematol., 11, 141–202.
   PubMed Web of Science ®Google Scholar
• Bodey, G. P., Buckley, M., Sathe, Y. S., Freireich, E. J. (1966). Quantitative relationship between circulating leukocytes and infection in patients with acutel leukemia. Ann. Intern. Med., 64, 328–340.
   PubMed Web of Science ®Google Scholar
• Motoyoshi, K., Takaku, F., Maekawa, T., et al. (1986). Protective effect of partially purified human colony-stimulating factor on granulocytopenia after anti-tumor chemotherapy. Exp. Hematol., 14, 1069–1075.
   PubMed Web of Science ®Google Scholar
• Bronchud, M. H., Scarffe, J. H., Thatcher, N., et al. (1987). Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small-cell lung cancer. Br. J. Cancer, 56, 809–813.
   PubMed Web of Science ®Google Scholar
• Morstyn, G., Campbell L., Souza, L. M., et al. (1988). Effects of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet, 1, 667–672.
   PubMed Web of Science ®Google Scholar
• Kodo, H., Tajika, K., Takahashi, S., et al. (1988). Acceleration of neutrophilic granulocyte recovery after bone marrow transplantation by the administration recombinant human granulocyte colony-stimulating factor. Lancet, 2, 38–39.
   PubMed Web of Science ®Google Scholar
• Nemunaitis, J., Singer, J. W., Buckner, C. D., et al. (1988). Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood, 72, 834–836.
   PubMed Web of Science ®Google Scholar
• Antman, K. S., Griffin, J. D., Elias, A., et al. (1988). Effects of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy induced myelosuppression. N. Engl. J. Med., 319, 593–598.
   PubMed Web of Science ®Google Scholar
• Ohno, R., Tomonaga, M., Kobayashi, T., et al. (1990). Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N. Engl. J. Med., 323, 871–877.
   PubMed Web of Science ®Google Scholar
• Griffin, J. D., Herrmann, Y. F., Wagner, W. K., Sabbath, K. D. (1986). Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia. Blood, 67, 1448–1453.
   PubMed Web of Science ®Google Scholar
• Vellenga, E., Young, D. C., Wagner, K., et al. (1987). The effect of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. Blood, 69, 1771–1776.
   PubMed Web of Science ®Google Scholar
• Estey, E. H., Dixon, D., Kantajian, H. M., et al. (1990). Treatment of poor prognosis, newly diagnosed acute myeloid leukemia with ara-c and recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 75, 1766–1769.
   PubMed Web of Science ®Google Scholar
• Duhrsen, U., Villeval, J. L., Body, J., et al. (1988). Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood, 72, 2074–2081.
   PubMed Web of Science ®Google Scholar
• Brandt, S. J., Peters, W. P., Atwater, S. K., et al. (1988). Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoetic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N. Engl. J. Med., 318, 869–876.
   PubMed Web of Science ®Google Scholar
• Miyauchi, J., Kelleher, C. A., Yang, Y. C., et al. (1987). The effect of three recombinant growth factors, IL-3, GM-CSF and G-CSF on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood, 70, 657–663.
   PubMed Web of Science ®Google Scholar
• Buchner, T., Hiddemann, W., Koenigsmann, M., et al. (1991). Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. Blood, 78, 1190–1197.
   PubMed Web of Science ®Google Scholar
• Stone, R. M., Berg, D. T., George, S. L., et al. (1995). Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. N. Engl. J. Med., 332, 1671–1677.
   PubMed Web of Science ®Google Scholar
• Rowe, J. M., Andersen, J. W., Mazza, J. J., et al. (1995). A randomized placebo-controlled phase III study of granulocyte—macrophage colony stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490). Blood, 86, 457–462.
   PubMed Web of Science ®Google Scholar
• Dombret, H., Chastang, C., Fenaux, P, et al. (1995). A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. N. Engl. J. Med., 332, 1678–1683.
   PubMed Web of Science ®Google Scholar
• Ohno, R., Naoe, T., Kanamaru, A., et al. (1994). A double blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemic. Blood, 83, 2086–2092.
   PubMed Web of Science ®Google Scholar
• Kantarjian, H. M., Estey, E. PL, O'Brien, S., et al. (1992). Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony stimulating factor in the treatment of patients with acute lymphoblastic leukemia. Blood, 79, 876–881.
   PubMed Web of Science ®Google Scholar
• Ottmann, O. G., Hoelzer, D. and Gracien, E., et al. (1995). Concomittant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: A randomized phase III trial. Blood, 86, 444–450.
   PubMed Web of Science ®Google Scholar
• Heil, G., Chadid, L. and Floelzer, D., et al. (1995). GM-CSF in a double blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia. Leukemia, 9, 3–9.
   PubMed Web of Science ®Google Scholar
• Bettlheim, P., Valent, P. and Andreeff, M., et al. (1991). Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood, 77, 700–711.
   PubMed Web of Science ®Google Scholar
• Estey, E., Thall, P. F. and Kantarjian, H., et al. (1992). Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-c + daunorubicin: Comparison to patients treated without GM-CSF. Blood, 79, 2246–2255.
   PubMed Web of Science ®Google Scholar
• Archimbaud, E., Fenaux, P. and Reiffers, J., et al. (1993). Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia. Leukemia, 7, 372–377.
   PubMed Web of Science ®Google Scholar
• Buchner, T., Hiddemann, W., Wormann, B., Rottmann, R., Maschmeyer, G. and Ludwig, W. D. (1993). The role of GM-CSF in the treatment of acute myeloid leukemia. Leuk-Lymphoma, 11, (Suppl 2): 21–4.
   PubMed Web of Science ®Google Scholar
• Estey, E., Thall, P. and Andreeff, M., et al. (1994). Use of granulocyte colony-stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome: Comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. J. Clin. Oncol., 12, 671–8.
   PubMed Web of Science ®Google Scholar
• Lieschke, G. J., Maher, D., Body, J., Kannourakis, G., Morstyn, G. and Metcalf, D. (1989). Effects of recombinant human granulocyte colony-stimulating factor in patients with advanced malignancy. Ann. Intern. Med., 110, 357–364.
   PubMed Web of Science ®Google Scholar
• Lieschke, G. J., Maher, D. and O'Connor, M., et al. (1990). Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration. Cancer Res., 50, 606–614.
   PubMed Web of Science ®Google Scholar
• Vadhan-Raj, S., Broxmeyer, H. E. and Hittelman, W. N. (1992). Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: Biology and Nature of response. Semin. Hematol, 29 (Suppl 3): 4–13.
   PubMed Web of Science ®Google Scholar
• Tolcher, A. W., Giusti, R. M., O'Shaughnessy, J. A. and Cowan, K. H. (1995). Arterial thrombosis associated with granulocyte-macrophage colony-stimulating factor (GM-CSF) administration in breast cancer patients treated with dose-intensive chemotherapy: A report of two cases. Cancer Invest., 13, 188–192.
   PubMed Web of Science ®Google Scholar
• Stephens, L. C., Haire, W. D., Schmit-Pokomy, K., Kessinger, A. and Kotulak, G. (1993). Granulocyte-macrophage colony-stimulating factor: high incidence of apheresis catheter thrombosis during peripheral stem cell collection. Bone Marrow Transplant, 11, 51–54.
   PubMed Web of Science ®Google Scholar
• Gratwohl, A., Dazzi, H. and Tichelli, A., et al. (1991). Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF). Schweiz Med Wochensch, 121, 413–7.
   PubMedGoogle Scholar
• Ho, A. D., Del-Valle, F. and Engelhard, M., et al. (1990). Mitoxantrone/high dose ara-c and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot study. Cancer, 66, 423–430.
   PubMed Web of Science ®Google Scholar
• Lieschke, G. J., Cebon, J. and Morstyn, G. (1989). Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 74, 2634–2643.
   PubMed Web of Science ®Google Scholar